ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) rose 0.8% during trading on Monday . The company traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares traded hands during mid-day trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Price Performance
The company has a current ratio of 5.06, a quick ratio of 4.29 and a debt-to-equity ratio of 1.70. The firm has a market capitalization of C$162.08 million and a PE ratio of -7.30. The business has a 50-day moving average of C$6.50 and a 200 day moving average of C$6.50.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- Comparing and Trading High PE Ratio Stocks
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What Are Some of the Best Large-Cap Stocks to Buy?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
